PMA P050037S117

Device
RADIESSE® Injectable Implant
Applicant
Merz North America, Inc.
Product code
LMH
Decision date
2023-01-06
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Approval for a change in the order of the Quality Control Plan II testing within the calcium hydroxylapatite (CaHA) particle production process.

Current openFDA PMA Record#

Device
RADIESSE® Injectable Implant
Applicant
Merz North America, Inc.
PMA number
P050037
Supplement
S117
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2023-01-06
Decision code
APPR
Date received
2022-08-18
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for a change in the order of the Quality Control Plan II testing within the calcium hydroxylapatite (CaHA) particle production process.